Takeda Launches Adynovate To Advance Prophylaxis Treatment For Hemophilia Patients in India
Takeda Launches Adynovate To Advance Prophylaxis Treatment For Hemophilia Patients in India. Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader expanded its innovative rare diseases portfolio in India … Read More









